re: Ann: CVac Improvement in 2nd Remission Da... Yes hopefully/surely Nasdaq will better appreciate this positive Announcement
The documents title says enough....Cvac Improvement in 2nd
Remission Data..to be delivered at the ACOS
The USA investors have a far greater appetite for Biotech stocks than we do in Oz
Ann: CVac Improvement in 2nd Remission Data Accep, page-6
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 29.0¢ | $732.3K | 2.454M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 113261 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 169614 | 3 |
View Market Depth
| Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |